Betamethasone Metabolite PK
Indication: Inflammation/Preterm Labor
PopPK model for betamethasone with 11-keto and 6β-hydroxy metabolites. Antenatal corticosteroid dosing optimization.
Drug Overview
Clinical Context
- Molecular Target
- Glucocorticoid Receptor
- Drug Class
- Small Molecule
- Therapeutic Area
- Immunology
- Indication
- Inflammation/Preterm Labor
- Route of Administration
- IV/IM
Model Information
- Model Type
- Parent-metabolite PK
- Category
- PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
Pharmacokinetic Parameters
PK Parameters
| Parameter | Value |
|---|---|
| Vc | 30-50 L |
| Vss | 120 L |
| t half | 35-54 h |
Additional Parameters
| Parameter | Value |
|---|---|
| ka IM | 0.3-0.5 h⁻¹ |
| dose IM | 12 mg (antenatal) |
Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.
About This Simulator
This interactive pharmacokinetic simulator for Betamethasone Metabolite allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK model characterizes the pharmacokinetics of this small molecule following iv/im administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Betamethasone Metabolite PK simulator?
This is a free, interactive pharmacokinetic simulator for Betamethasone Metabolite used in Inflammation/Preterm Labor. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Betamethasone Metabolite belong to?
Betamethasone Metabolite is classified as a Small Molecule that targets Glucocorticoid Receptor. It is used in the Immunology therapeutic area.
What route of administration does this model simulate?
This simulator models IV/IM administration of Betamethasone Metabolite. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
What is the half-life of Betamethasone Metabolite?
Based on the published model parameters, the elimination half-life of Betamethasone Metabolite is approximately 35-54 h. Note that half-life can vary based on patient-specific factors such as body weight, organ function, and genetic polymorphisms.
Related Simulators
Xtandi (Enzalutamide) PK Simulator
Metastatic castration-resistant prostate cancer
Xolair (Omalizumab) PK Simulator
Moderate-to-severe allergic asthma
Xarelto (Rivaroxaban) PK Simulator
Stroke prevention in atrial fibrillation
Vyndaqel (Tafamidis) PK Simulator
Transthyretin amyloid cardiomyopathy
Verzenio (Abemaciclib) PK Simulator
HR+/HER2- metastatic breast cancer
Trikafta (Elexacaftor/Tezacaftor/Ivacaftor) PK Simulator
Cystic fibrosis
Ready to Simulate?
Launch the Betamethasone Metabolite simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community